SG Americas Securities »

Carisma Therapeutics shares owned by SG Americas Securities

Quarter-by-quarter ownership of Carisma Therapeutics (CARM) shares owned by SG Americas Securities from 13F filings

Historical chart of SG Americas Securities investment in Carisma Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Carisma Therapeutics held by SG Americas Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Carisma Therapeutics by SG Americas Securities

Quarter filed Position value Share count Share price at filing
2023-12-31 $43k 15k 2.93
2023-09-30 $58k 14k 4.25

More positions owned by SG Americas Securities

Amazon (AMZN)
iShares MSCI EAFE Index Fund (EFA)
SPDR Gold Trust (GLD)
Cisco Systems (CSCO)
Invesco Qqq Tr Opt Call Option
Apple (AAPL)
iShares MSCI Emerging Markets Indx (EEM)
Meta Platforms Opt Call Option
Spdr S&p 500 Etf (SPY)
iShares Russell 2000 Index (IWM)
Abbvie (ABBV)
Amazon Opt Call Option
Broadcom (AVGO)
Amgen (AMGN)
Caterpillar (CAT)

View all positions for SG Americas Securities

Top funds holding Carisma Therapeutics

Tpg Gp A
Vanguard Group
Bank of New York Mellon
Charles Schwab Investment Management
Arrowstreet Capital, Limited Partnership
Bank of America Corporation
Barclays
Rhumbline Advisers
UBS Group
Dimensional Fund Advisors
Blodgett Wealth Advisors
Two Sigma Investments
Jpmorgan Chase & Co
SG Americas Securities
American International

View all funds holding Carisma Therapeutics